Search
Alterity Therapeutics Ltd
ATHEAdd to Watchlist
1.960USD
-0.135-6.44%
Close 11-13 16:00（ET）
35.69MMarket Cap
LossP/E TTM
Alterity Therapeutics Ltd (ATHE) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts giving stock ratings to Alterity Therapeutics Ltd in the past month.
Buy
1 Strong Buy
4 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
12.600USD+483.33%
ATHE Analyst Recommendation Trends
In the current month, ATHE has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ATHE average Analyst price target in the last month is 12.600.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
1
1
1
1
0
0
0
0
4
4
2
2
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
3
3
1
1
1
1
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025H1
FY2025H2
FY2026
Forecast
--
--
--
Actual
-0.55
-0.00
-0.90
Surprise
--
--
--
FAQs
What is Alterity Therapeutics Ltd's expected revenue for the next quarter?
Alterity Therapeutics Ltd's expected revenue is 1.80M.
What is Alterity Therapeutics Ltd's price target?
Analysts forecast that Alterity Therapeutics Ltd's price target is USD 11.00, with the highest forecast at USD 12.00 and the lowest forecast at USD 10.00.
What is the analyst rating for Alterity Therapeutics Ltd?
Based on the ratings of Alterity Therapeutics Ltd's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.